Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence and predictors of low bone mineral density in Myasthenia gravis.

Arquivos de neuro-psiquiatria·2026

Same author

Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10.

Cerebellum (London, England)·2026

Same author

Somatosensory evoked potentials in neuromyelitis optica spectrum disorders.

Neurological research·2026

Same author

Patient journey and treatment pattern in myasthenia gravis: real-world data from the Brazilian public health system.

Arquivos de neuro-psiquiatria·2026

Same author

Paul Hoffmann and the cutaneous silent period test.

Arquivos de neuro-psiquiatria·2025

Same author

A TPM2 mutation causes congenital myopathy with fibre-type disproportion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024

Same journal

Correlation Is Not Prediction: Reassessing Predictive MRI Evidence in Guidelines for Persons With Relapsing-Remitting Multiple Sclerosis.

Journal of central nervous system disease·2026

Same journal

Beyond Time Is Brain: The Time, Tissue, and Systems Framework for Acute Stroke.

Journal of central nervous system disease·2026

Same journal

Heterogeneity of Microglia in Ischemic Stroke from the Perspective of Single-Cell RNA Sequencing: Subset Characteristics, Mechanisms and Therapeutic Potential.

Journal of central nervous system disease·2026

Same journal

Machine Learning-Based Detection of Parkinson's Disease From Arabic Speech: A Cross-Linguistic Validation Study.

Journal of central nervous system disease·2026

Same journal

Depression, Anxiety, and Stress After Acquired Brain Injury: The Role of Cognitive Reserve in Patients and Caregivers 'Symptoms.

Journal of central nervous system disease·2026

Same journal

GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence.

Journal of central nervous system disease·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 7, 2025

Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination

Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination

Published on: July 29, 2015

Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorders.

Otto Jesus Hernandez Fustes¹, Cláudia S K Kay¹, Paulo José Lorenzoni¹

¹Neurology Service, Clinics Hospital Complex at Universidade Federal do Paraná, Curitiba, Brazil.

Journal of Central Nervous System Disease

|January 7, 2022

Summary

This summary is machine-generated.

Visual evoked potentials (VEPs) reveal increased P100 latency in neuromyelitis optica spectrum disorders (NMOSDs), indicating optical pathway involvement. This non-invasive test aids in diagnosing NMOSD.

Keywords:

Neuromyelitis optica spectrum disorders optic nerve visual evoked potentials

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Related Experiment Videos

Last Updated: Oct 7, 2025

Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination

Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination

Published on: July 29, 2015

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Area of Science:

Neurophysiology
Ophthalmology
Neurology

Background:

Neuromyelitis optica spectrum disorders (NMOSDs) are rare, antibody-mediated central nervous system diseases targeting the spinal cord and optic nerves.
Visual evoked potentials (VEPs) are established diagnostic tools for multiple sclerosis, but their utility in NMOSD is less explored.

Observation:

This study prospectively evaluated VEP responses in 13 patients diagnosed with NMOSD.
VEPs were recorded according to International Federation of Clinical Neurophysiology standards.

Findings:

A significant increase in P100 latency was observed in 20 of 24 evaluated eyes, without amplitude changes.
No VEP response was obtained in 6 eyes.

Implications:

VEP assessment demonstrates significant optical pathway involvement in NMOSD patients.
VEP is a valuable, non-invasive, and cost-effective neurophysiological tool for NMOSD diagnosis.